Want to see STLN full AI Analyst Report?
Starling Oncology Institute (STLN) Revenue
213 Followers
Starling Oncology Institute Revenue
Starling Oncology Institute had a revenue of 161.28M in the quarter ending Jun 30, 2026, with 9.39%. This bring the company's revenue in the last twelve months to 587.24M, Increased 7.60%. In the fiscal year ending Dec 31, 2025, Starling Oncology Institute had annual revenue of 502.73M with 27.79% growth.
- Revenue (ttm)
- 587.24M
- Revenue Growth
- 38.38%
- P/S Ratio
- 1.24
- Revenue/Employee
- $784,289
- Employees
- 641
- Market Cap
- $624.89M
Revenue Chart
Starling Oncology Institute Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 502.73M | 109.32M | 27.79% |
| Dec 31, 2024 | 393.41M | 69.17M | 21.33% |
| Dec 31, 2023 | 324.24M | 71.76M | 28.42% |
| Dec 31, 2022 | 252.48M | 49.48M | 24.37% |
| Dec 31, 2021 | 203.00M | 15.49M | 8.26% |
| Dec 31, 2020 | 187.51M | 32.11M | 20.66% |
| Dec 31, 2019 | 155.41M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.